Dr Hakim (Abdelhakim) Hammach

Advisory Board Member

Dr. Hakim Hammach is the Managing Director of Investments at Riyadh Valley Company (RVC) and joined the Prokarium board in January 2018 as deputy member for Dr Khalid Al-Saleh. Dr Hammach has over 20 years of leadership and management experience in R&D, venture capital investing and strategy consulting. Before joining RVC he was a Senior Strategy Consultant with Accenture in Philadelphia, where he advised leading global organisations in the US and Europe on issues of investment and growth strategy. Before joining Accenture, he was a Venture Capital Investment Consultant with Aurora Funds in North Carolina’s Research Triangle Park. Prior to this, he was a Principal Scientist with Boehringer Ingelheim Pharmaceuticals. He is an inventor with 18 US patents, covering novel anti-inflammatory drug candidates and has co-authored numerous articles in leading international journals and magazines. He earned a Ph.D. in Chemistry from the University of Vermont, served as a post-doctoral fellow at the University of Pennsylvania and holds a MBA from Duke University, Fuqua School of Business in Finance and Strategy.